Earnings updates, royal seal of approval, or more to come?
Calida Smylie Tue, 14 Apr 2015
Trilogy International [NZX:TIL] maintains its recent share price hike was due to last month’s upbeat earnings forecast – but NBR readers are not convinced.
The skincare products and scented candle maker was issued a ‘please explain’ notice yesterday by the NZX, which was concerned Trilogy was
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).